COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2408: Articles 24071-24080  | Next

Cold-adapted live attenuated SARS-CoV-2 vaccine completely protects human ACE2 transgenic mice from SARS-CoV-2 infection
Seo, S. H., Jang, Y.
10.1101/2020.08.04.235689 — Posted: 2020-08-04
SARS-CoV-2 genome analysis of strains in Pakistan reveals GH, S and L clade strains at the start of the pandemic
Ghanchi, N. K., Masood, K. I., Nasir, A., Khan, W., Abidi, S. H., Shahid, S., Mahmood, S. F., Kanji, A. R., Razzak, S. A., Ansar, Z., Islam, N., Dharejo, M. B., Hasan, Z., Hasan, R.
10.1101/2020.08.04.234153 — Posted: 2020-08-04 Discussion: Onsite
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: results from a large-scale screening program based on rapid serological testing.
Carozzi, F. M., Cusi, M. G., Pistello, M., Galli, L., Bartoloni, A., Anichini, G., Azzari, C., Emdin, M., Gandolfo, C., Maggi, F., Mantengoli, E., Moriondo, M., Moscato, G., Paganini, I., Passino, C., Profili, F., Voller, F., Zappa, M., Quattrone, F., Rossolini, G. M., Francesconi, P., SARS-CoV-2 Serosurvey Tuscan Working Group
10.1101/2020.07.30.20149567 — Posted: 2020-08-04
Overcoming Reporting Delays Is Critical to Timely Epidemic Monitoring: The Case of COVID-19 in New York City
Harris, J. E.
10.1101/2020.08.02.20159418 — Posted: 2020-08-04
Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2
Hassan, S. S., Attrish, D., Ghosh, S., Pal Choudhury, P., Roy, B.
10.1101/2020.08.04.236653 — Posted: 2020-08-04
SCV-2000bp: a primer panel for SARS-CoV-2 full-genome sequencing
Speranskaya, A., Kaptelova, V., Valdokhina, A., Bulanenko, V., Samoilov, A., Korneenko, E., Shipulina, O., Akimkin, V.
10.1101/2020.08.04.234880 — Posted: 2020-08-04
A valid protective immune response elicited in rhesus macaques by an inactivated vaccine is capable of defending against SARS-CoV-2 infection
Chen, H., Xie, Z., Long, R., Fan, S., Li, H., He, Z., Xu, K., Liao, Y., Wang, L., Zhang, Y., Li, X., Dong, X., Mou, T., Zhou, X., Yang, Y., Guo, L., Yang, J., Zheng, H., Xu, X., Li, J., Liang, Y., Li, D., Zhao, Z., Hong, C., Zhao, H., Jiang, G., Che, Y., Yang, F., Hu, Y., Wang, X., Pu, J., Ma, K., Wang, L., Chen, C., Duan, W., Shen, D., Zhao, H., Jiang, R., Deng, X., Li, Y., Zhu, H., Zhou, J., Yu, L., Xu, M., Yang, H., Yi, L., Zhou, Z., Yang, J., Duan, N., Yang, H., Zhao, W., Yang, W., Li, C., Liu, L., Li, Q.
10.1101/2020.08.04.235747 — Posted: 2020-08-04
A distinct innate immune signature marks progression from mild to severe COVID-19
Chevrier, S., Zurbuchen, Y., Cervia, C., Adamo, S., Raeber, M. E., de Souza, N., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., Stüssi-Helbling, M., Huber, L. C., Schaer, D. J., Nilsson, J., Boyman, O., Bodenmiller, B.
10.1101/2020.08.04.236315 — Posted: 2020-08-04
Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Räber, M. E., Yang, L., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., Stüssi-Helbling, M., Huber, L. C., Schaer, D., Bodenmiller, B., Boyman, O., Nilsson, J.
10.1101/2020.08.04.236521 — Posted: 2020-08-04 Discussion: Onsite | Offsite
SARS-CoV-2 infection, disease and transmission in domestic cats
Gaudreault, N. N., Trujillo, J. D., Carossino, M., Meekins, D. A., Morozov, I., Madden, D. W., Indran, S. V., Bold, D., Balaraman, V., Kwon, T., Libanori Artiaga, B., Cool, K., Garcia-Sastre, A., Ma, W., Wilson, W. C., Henningson, J., Balasuriya, U. B., Richt, J. A.
10.1101/2020.08.04.235002 — Posted: 2020-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).